ACADIA PHARMACEUTICALS INC (ACAD)
US0042251084 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -61.29M | -215.98M | -167.87M | -281.58M | -235.26M | |||
| Depreciation Amortization | 5.55M | 2.03M | 3.35M | 2.94M | 2.77M | |||
| Change In Working Capital | 18.13M | 37.99M | -24.82M | 11.04M | 3.71M | |||
| Taxes Paid | 5.85M | 2.19M | 1.04M | 1.11M | 1.60M | |||
| Other non cash items | 54.30M | 61.92M | 63.69M | 131.45M | 77.66M | |||
| OPERATING CASH FLOW | 16.70M | -114.04M | -125.66M | -136.17M | -151.13M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -40.05M | 0.00 | -1.12M | -7.59M | -1.13M | |||
| Other Investing Activity | 72.05M | 73.24M | -69.98M | 200.10M | -164.71M | |||
| INVESTING CASH FLOW | 32.00M | 73.24M | -71.10M | 192.51M | -165.84M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 25.13M | 8.20M | 18.16M | 81.00M | 371.85M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 25.13M | 8.20M | 18.16M | 81.00M | 371.85M | |||
| Exchange Rate Effect | -18.00K | 10.00K | 10.00K | -10.00K | 0.00 | |||
| CHANGE IN CASH | 73.81M | -32.59M | -178.59M | 137.33M | 54.88M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 16.70M | -114.04M | -125.66M | -136.17M | -151.13M | |||
| Capital Expenditure | -40.05M | 0.00 | -1.12M | -7.59M | -1.13M | |||
| FREE CASH FLOW | -23.35M | -114.04M | -126.78M | -143.76M | -152.26M | |||
All data in USD